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Abstract
Purpose The evidence from the literature regarding the association of dietary factors and risk of prostate cancer is 
inconclusive.
Methods A nutrient-wide association study was conducted to systematically and comprehensively evaluate the associations 
between 92 foods or nutrients and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutri-
tion (EPIC). Cox proportional hazard regression models adjusted for total energy intake, smoking status, body mass index, 
physical activity, diabetes and education were used to estimate hazard ratios and 95% confidence intervals for standardized 
dietary intakes. As in genome-wide association studies, correction for multiple comparisons was applied using the false 
discovery rate (FDR < 5%) method and suggested results were replicated in an independent cohort, the Netherlands Cohort 
Study (NLCS).
Results A total of 5916 and 3842 incident cases of prostate cancer were diagnosed during a mean follow-up of 14 and 
20 years in EPIC and NLCS, respectively. None of the dietary factors was associated with the risk of total prostate cancer in 
EPIC (minimum FDR-corrected P, 0.37). Null associations were also observed by disease stage, grade and fatality, except 
for positive associations observed for intake of dry cakes/biscuits with low-grade and butter with aggressive prostate cancer, 
respectively, out of which the intake of dry cakes/biscuits was replicated in the NLCS.
Conclusions Our findings provide little support for an association for the majority of the 92 examined dietary factors and 
risk of prostate cancer. The association of dry cakes/biscuits with low-grade prostate cancer warrants further replication 
given the scarcity in the literature.
Keywords Diet · Nutrition · Epidemiology · Cohort study · Prostate cancer
Introduction
Prostate cancer is the most commonly diagnosed cancer in 
men residing in high-income countries [1]. Incidence rates 
of the disease, mostly at the localized stage, differ remark-
ably worldwide in large part because of the different uptake 
of prostate-specific antigen (PSA) test for screening but pos-
sibly also due to genetic and environmental factors [1, 2]. 
Among the environmental factors, nutrition-related factors 
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such as obesity have been suggested to play a role in pros-
tate cancer risk, but with different associations according 
to disease stage and grade [3–6]. However, the evidence for 
specific foods or nutrients affecting prostate cancer is incon-
sistent, and no specific dietary factors have been robustly 
associated with prostate cancer risk [3–5]. A potential reason 
for this inconsistency is that foods and nutrients are strongly 
correlated, and it is difficult to decipher their independent 
effects.
Therefore, we conducted a nutrient-wide association 
study (NWAS) to systematically and comprehensively evalu-
ate the association between 92 foods or nutrients and risk of 
prostate cancer in the European Prospective Investigation 
into Cancer and Nutrition (EPIC) using proper adjustment 
for multiplicity of comparisons and replication of emerg-
ing findings in an independent population, the Netherlands 
Cohort Study (NLCS), as is commonly done in genome-
wide association studies (GWAS). The NWAS method has 
been used to identify novel dietary risk associations for type 
2 diabetes, blood pressure and cancer [7–10].
Materials and methods
Study population
EPIC is a large multi-center European prospective study 
aiming to identify the role of environmental, lifestyle and 
dietary factors on risk of cancer and other chronic diseases. 
Briefly, 521,324 participants, aged mostly between 35 and 
70 years, were recruited from 1992 to 2000 from 23 cent-
ers across 10 European countries. More information about 
the EPIC cohort can be found elsewhere [11]. The current 
analysis included participants from eight countries, as EPIC 
centers in France and Norway recruited only women. Out of 
the 153,426 male participants in EPIC, 122,998 individuals 
were used in the current analysis after excluding men with 
prevalent cancer at recruitment except of non-melanoma 
skin cancer (N = 3972), those with lack of follow-up infor-
mation (N = 1447) and lack of lifestyle and dietary informa-
tion at recruitment (N = 2916), men with extreme values (top 
or bottom 1%) on the energy intake-to-energy requirement 
ratio (N = 2850), and men with missing values for the study 
confounders (N = 19,243). All the participants gave written 
informed consent, and the study was approved by the ethical 
review boards of the International Agency for Research on 
Cancer (IARC) and all local institutions.
NLCS is a prospective cohort study established in 1986 
and includes 120,852 participants aged between 55 and 
69 years recruited from 204 computerized population reg-
istries across the Netherlands, of which 58,279 were men 
[12]. The NLCS used a case–cohort approach for efficiency 
reasons, where a subcohort of 5000 participants, of which 
2411 men, was selected at random immediately after base-
line [12]. This subcohort has been followed up biannually 
to estimate the person-time at risk. Out of the 2411 male 
participants in the NLCS subcohort, 1961 individuals were 
used in the current analysis after excluding 75 men with 
prevalent cancer at recruitment, 279 men with incomplete or 
inconsistent dietary data, and 96 men with missing data on 
confounders. The NLCS was approved by the institutional 
review boards of the TNO Quality of Life research institute 
(Zeist, The Netherlands) and Maastricht University (Maas-
tricht, The Netherlands).
Assessment of dietary factors
The consumption of foods over the preceding 12 months 
was assessed at baseline in EPIC using country-specific food 
questionnaires including a range of 88–266 items. Question-
naires were self-administered, except in Greece, Spain and 
Ragusa in Italy, where interviewers were used. The EPIC 
Nutrient Database (ENDB) was used to calculate standard-
ized nutrient intakes [13]. Further details on the diet ques-
tionnaires are described elsewhere [11]. In total, 92 dietary 
factors, of which 63 foods and 29 nutrients, that were avail-
able in at least six out of the eight countries were included 
in the current analysis.
In NLCS, food consumption in the previous 12 months 
was assessed at baseline using a semi-quantitative 150-item 
food frequency questionnaire, which has been validated and 
tested for reproducibility [14, 15]. The Dutch food composi-
tion table was used to convert the data from the question-
naire to nutrient intake [16].
Assessment of prostate cancer
A total of 5916 men were diagnosed with first incident 
prostate cancer in EPIC based on the International Clas-
sification of Diseases 10th revision code (ICD-10: C61), 
the vast majority of which were adenocarcinomas (94%), a 
remaining 5% were unclassified tumors and 1% were other 
subtypes. Cancers were identified through population-based 
cancer registries in Denmark, Italy, The Netherlands, Spain, 
Sweden, and the United Kingdom (UK). Active follow-up, 
including direct or next of kin communication, or combina-
tion of different sources of ascertainment including health 
insurance records, regional health departments, municipal-
ity registries, hospital records and pathology registries were 
used in Greece and Germany. Of the 5916 incident prostate 
cancer cases, 3465 (58.5%) had stage information and 3742 
(63.2%) had grade information. A total of 2321 tumors were 
classified as localized (i.e., tumor-node-metastasis [TNM] 
staging score of T0–T2 and N0/NX and M0, or stage coded 
in the recruitment center as localized) and 1144 as advanced 
prostate cancer (i.e., T3–T4 and/or N1–N3 and/or M1, or 
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stage coded in the recruitment center as metastatic). Fur-
ther, 3164 tumors were classified as low-grade (i.e., Glea-
son score of < 8, or grade coded as well differentiated or 
moderately differentiated) and 578 as high-grade prostate 
cancer (i.e., Gleason score ≥ 8, or grade coded as poorly dif-
ferentiated or undifferentiated). Moreover, 1770 cancer cases 
were characterized as aggressive if they were recorded as 
advanced stage or high-grade cancer or had PSA value at 
diagnosis over 20 ng/mL. During the follow-up period, 709 
fatal cases of prostate cancer were identified.
A total of 3842 cases of incident prostate cancer were 
diagnosed in NLCS through periodic record linkages to the 
Netherlands Cancer Registry. Information about the stage at 
diagnosis was available for 3563 (92.7%) cases, where 2312 
cases were categorized as localized and 1251 as advanced. 
Information on prostate cancer differentiation grade was 
available for 3446 (89.6%) cases, of which 2593 were clas-
sified as low-grade and 853 as high-grade. Finally, 1667 
cancer cases were characterized as aggressive.
Statistical analysis
Each of the 92 dietary factors was individually explored in 
relation to prostate cancer risk in EPIC using Cox propor-
tional hazard regression models. Age at entry was used as 
the time variable in all models. As age at exit was chosen 
either the age at cancer diagnosis or the age at death or age 
at the last follow-up, whichever happened first. The intake of 
nutrients was energy adjusted using the residual method in 
order to control for possible confounding due to total energy 
intake [17]. All dietary factors entered the models as stand-
ardized continuous variables to reflect associations per one 
standard deviation increase in consumption. As a sensitivity 
analysis, the dietary factors were also modeled as categorical 
variables using quartiles, but the results were very similar 
and therefore not reported herein.
The statistical models in EPIC were stratified by age at 
recruitment (< 40, 40–44.9, 45–49.9, 50–54.9, 55–59.9, 
60–64.9, 65–69.9, 70–74.9, ≥ 75) and recruitment center in 
order to control for center specific differences like question-
naire design and follow-up procedures [18]. Covariates were 
selected a priori as potential confounders, which were total 
energy intake (kcal, continuous), smoking status (never, for-
mer, current), BMI (kg/m2, < 20, 20–22.9, 23–24.9, 25–29.9, 
30–34.9, ≥ 35), physical activity (inactive, moderately inac-
tive, moderately active, active) [19], diabetes history (no, 
yes), and education status (none/primary, technical/profes-
sional, secondary, longer). When we further adjusted for 
height, the results were similar and therefore height was 
not included in the final models. In the primary analysis 
participants with missing confounder values were excluded, 
but when the analysis was repeated using missing indica-
tors identical results were observed (results not shown). 
In the NLCS, Prentice-weighted Cox proportional hazards 
regression models with robust estimation of standard errors 
were used to suit the case-cohort design [20]. The models in 
the NLCS were adjusted for the aforementioned confound-
ers, and further for family history of prostate cancer (yes, 
no). The proportionality of the hazards was verified in both 
cohorts by checking the slope of the Schoenfeld residuals, 
and no violations were identified.
To account for multiple comparisons in the EPIC study, 
we estimated the false discovery rate (FDR) for each dietary 
factor. The FDR is the proportion of false positive results 
among the statistically significant results, and was com-
puted using an analytical method described elsewhere [7, 
8]. Briefly, a “null distribution” of p values was created by 
shuffling cancer status and years of follow-up and rerunning 
the Cox models. Then, the FDR was calculated as the ratio 
of the proportion of results that were nominally statistically 
significant at the 5% level in the null distribution and the 
proportion of nominally statistically significant results in 
the original analysis. As a sensitivity analysis, we calculated 
the FDR using the sequential p value approach proposed by 
Benjamini and Hochberg, but the obtained results were very 
similar [21]. Dietary factors with FDR value less than 5% 
were selected for replication in the NLCS study. Finally, a 
random-effects meta-analysis was performed to combine the 
results from the two cohorts and give an overall result. The 
analysis was performed using the R programming language 
and STATA (version 13).
Results
After a mean follow-up time of 14 years for 122,998 men 
in EPIC, 5916 incident cases of total prostate cancer were 
identified. Table 1 shows the baseline characteristics of the 
study participants. In EPIC, the mean BMI was 26.6 kg/m2, 
about 30% were current smokers and had higher education 
levels while, over the half were physically active and only 
4% had a history of diabetes. In NLCS, the mean BMI was 
24.9 kg/m2, around 35% of the participants were smokers 
and 20% had received higher education. Moreover, the par-
ticipants were spending about 81 min per day on average on 
non-occupational physical activities and about 3% of them 
had a history of diabetes.
Of the 92 dietary factors that were evaluated in EPIC, 
three (dry cakes-biscuits, sauces, confectionary [non-choc-
olate]) were positively associated with total prostate can-
cer risk, while seven (total fruits, citrus fruits, vitamin B6, 
stone fruits, beer-cider, vitamin C, mushrooms) showed a 
protective association at the nominal statistical significance 
level (P ≤ 0.05) (Fig. 1 and supplemental Table 1). How-
ever, no dietary factor retained an association after correct-
ing for multiple comparisons (smallest FDR P, 0.37). The 
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results were similar and null associations were observed 
after correcting for multiple comparisons for almost all die-
tary variables and risk of prostate cancer by stage, grade or 
fatality with only two exceptions (Fig. 1 and supplemental 
Tables 2–7). Intakes of dry cakes/biscuits and butter were 
associated with a higher risk of low-grade (HR, 1.07; 95% 
CI 1.03–1.11; FDR P, 0.01) and aggressive prostate can-
cer (HR, 1.08; 95% CI, 1.04–1.13; FDR P, 0.02), respec-
tively (Fig. 1 and supplemental Tables 4, 6). There was no 
evidence of heterogeneity of the latter two associations by 
prostate cancer grade, but evidence of heterogeneity was 
observed only for butter consumption by prostate can-
cer stage (Phetereogeneity, 0.02; HR, 0.98; 95% CI 0.94–1.02 
for localized disease and HR, 1.09; 95% CI 1.03–1.15 for 
advanced disease). There was consistency in the results for 
both associations when they were analyzed separately in 
each EPIC country (Supplemental Fig. 1).
In the NLCS, we then evaluated the two suggested asso-
ciations from the analysis in EPIC (Fig. 2). The association 
for dry cakes/biscuits and risk of low-grade prostate cancer 
was replicated (HR 1.09; 95% CI 1.02–1.16), whereas the 
association for butter and aggressive prostate cancer risk 
was not (HR, 1.03; 95% CI 0.96–1.11). However, the asso-
ciation estimates in the NLCS were similar to the estimates 
observed in EPIC, and we conducted therefore a meta-analy-
sis, where positive associations were observed for both foods 
(dry cakes/biscuits: HR, 1.08; 95% CI 1.04–1.11; butter: HR 
1.07; 95% CI 1.02–1.11).
Discussion
In the current study, we used the NWAS approach to evalu-
ate the association between a large number of dietary factors 
and risk of total prostate cancer and cancer by stage, grade 
and fatality. After adjusting for multiple comparisons, no 
dietary variable was associated with risk of total prostate 
cancer or most other prostate cancer outcomes including 
mortality in EPIC. However, positive associations emerged 
for the consumption of dry cakes/biscuits and butter with 
risk of low-grade and aggressive prostate cancer, respec-
tively, the first association of which was replicated in NLCS.
The current literature evidence supports the main find-
ings of our analysis, as there is no consistent evidence for 
association between any dietary factor and risk of prostate 
cancer, which was confirmed by the World Cancer Research 
Fund (WCRF) Third Expert Report and a recent compre-
hensive review [3, 4]. The literature evidence for an asso-
ciation between dry cakes/biscuits and butter with risk of 
prostate cancer is very sparse. A report from the Malmö 
Diet and Cancer cohort showed that high intake of cakes 
and biscuits was associated with an increased risk of non-
aggressive prostate cancer (top vs. bottom intake: HR 1.45; 
95% CIs 1.03–2.02), and null associations were observed 
for aggressive or total prostate cancer risk [22]. This cohort 
included 8128 men, of whom 817 developed prostate cancer, 
and analyzed 16 dietary exposures related to carbohydrates, 
fiber and their food sources without correcting for multi-
ple comparisons. In agreement, we observed in the current 
NWAS analysis that intake of dry cakes/biscuits was posi-
tively associated with low-grade disease after multiplicity 
correction and replication approaches, but also with local-
ized and total prostate cancer risk before multiplicity correc-
tion. However, we observed null associations for intake of 
dry cakes/biscuits and risk of the more clinically important 
outcomes of advanced stage, high grade, aggressive and fatal 
prostate cancer. A potential explanation for the positive asso-
ciation between cakes and biscuits with low-grade prostate 
cancer could be the high concentration of refined carbohy-
drates in cakes and biscuits. High consumption of refined 
carbohydrates can lead to hyperinsulinemia followed by the 
activation of the insulin like growth factor (IGF)-1 axis and 
inflammatory pathways [23]. However, several prospective 
cohort studies have shown no association between glycae-
mic index or load and prostate cancer risk [24–26]. Another 
explanation could be the high levels of fat and especially 
saturated fat in cakes and biscuits, but null associations 
have been reported for total or saturated fat consumption in 
relation to risk of any prostate cancer outcome in the meta-
analyses conducted by the WCRF Third Expert Report [3].
The current NWAS study reported a positive associa-
tion between butter consumption and risk of aggressive 
prostate cancer after multiplicity correction and replication 
approaches, but also with advanced stage disease before 
multiplicity correction. The literature evidence is again very 
sparse, and a recent meta-analysis of two prospective studies 
found no association with total prostate cancer risk (high vs. 
low intake; RR 1.03; 95% CIs 0.89–1.20) in agreement with 
Table 1  Distribution of demographic characteristics at baseline in 
EPIC and NLCS
EPIC European Prospective Investigation into Cancer and Nutrition, 
NLCS Netherlands Cohort Study, SD standard deviation, BMI body 
mass index, kcals kilocalories
a Distribution data in NLCS are from the subcohort
Characteristics EPIC NLCSa
No. of participants 122,998 58,279
Mean age at recruitment (SD) 51.6 (9.8) 61.3 (4.2)
Mean BMI (SD) 26.6 (3.7) 24.9 (2.6)
Mean energy intake in kcals (SD) 2429 (663) 2164 (498)
% Current smokers 30.8 35.3
% Active/moderately active 50.9
Mean physical activity, min/day (SD) 80.6 (67.5)
% History of diabetes 4.0 3.3
% Higher than secondary education 28.3 19.6
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our findings [27]. A report from the Melbourne Collabora-
tive Cohort Study observed no association between butter 
consumption and risk of aggressive prostate cancer (high vs. 
low intake; RR 1.03; 95% CIs 0.53–2.00), but included only 
107 aggressive cases [28]. Another report from the Health 
Professionals Follow-up Study observed an increased risk 
of metastatic prostate cancer (249 cases; top vs. bottom 
consumption; RR 1.42; 95% CI 1.00–2.00), but this asso-
ciation was attenuated and lost statistical significance after 
additional controlling for saturated fat and a-linolenic acid 
[29]. It is likely that butter consumption reflects to an extent 
intake of dairy products, which have been associated with 
an increased risk of total prostate cancer in several prospec-
tive studies [27]. However, the association of dairy products 
with aggressive or fatal disease is inconsistent and received 
a weak evidence grading in a recent critical appraisal of the 
literature [4].
The strengths of the current study were the ability to 
systematically examine a large number of dietary factors in 
relation to all prostate cancer outcomes, including the most 
clinically relevant outcomes of aggressive or fatal disease, 
while taking into account the multiple comparisons by cal-
culating the FDR and replicating results in an independent 
cohort, which provided further confidence in our findings. 
The NWAS approach necessitates the reporting of all results, 
and thus it addresses the issue of selective reporting of sta-
tistically significant results that is quite prevalent in obser-
vational epidemiology [8, 30]. Potential limitations of this 
study included the single dietary assessment at baseline and 
the use of self-reported questionnaires, which could lead to 
non-differential misclassification of dietary consumption and 
may drive the results towards the null. Men with any miss-
ing values for the study confounders (12.5%) were excluded 
from the analysis, which could lead to selection bias, but 
the excluded participants had a similar profile to those that 
remained, and the results were identical when the analysis 
was repeated using missing indicator values. Furthermore, 
it is possible that there might be an association for foods or 
nutrients that were not included in this analysis or for spe-
cific dietary patterns. Moreover, we did not account for the 
correlations between foods and nutrients as it would reduce 
the number of statistical comparisons and the correspond-
ing statistical significance threshold. The number of fatal 
prostate cancer cases was relatively small despite the large 
number of total prostate cancer cases and the long follow-
up period, and this analysis might lack statistical power. 
Finally, we cannot totally exclude the possibility of residual 
confounding, although we adjusted for several potential 
confounders.
In summary, no association was found for the majority of 
the 92 examined dietary factors and risk of prostate cancer. 
The associations of dry cakes/biscuits with low-grade pros-
tate cancer and of butter with aggressive disease warrant 
further replication given the scarcity in the literature and the 
lack of clear mechanistic pathways.
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